Visteon's stock price soared 5.33% during intraday trading on Friday, reflecting strong positive momentum in the market.

The surge appears to be driven by a series of positive analyst actions from major financial institutions. Deutsche Bank raised its price target on Visteon to $121 from $115 while maintaining a Buy rating. Similarly, UBS increased its price target to $130 from $120. Goldman Sachs maintained its Buy rating on the stock, while RBC Capital reiterated its Buy rating with a $117 price target, and Baird maintained its Outperform rating.

These analyst actions, particularly the price target increases, have likely boosted investor confidence in Visteon's prospects, contributing to the significant intraday price appreciation.